Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2022 | The clinical importance of left atrial infiltration in ATTR and cardiac AL amyloidosis

Marianna Fontana • 14 Sep 2022
ISA 2022
Amyloidosis Rare Diseases

Marianna Fontana, MD, PhD, University College London, London, UK, comments on the clinical importance of left atrial infiltration in patients with cardiac AL or ATTR amyloidosis, highlighting the need to guide treatment decisions based on the presence or absence of mechanical contraction. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consultancy for: Alnylam, Ionis, Intellia, Novonordisk, Janssen, Caelum, Pfizer, Bridgbio, Eidos

More from Marianna Fontana

Phenotypic variability & getting to the right diagnosis in AL amyloidosis
0:57
Phenotypic variability & getting to the right diagnosis in AL amyloidosis
Marianna Fontana • 14 Sep 2022
Imaging techniques to detect early cardiac amyloid infiltration
1:21
Imaging techniques to detect early cardiac amyloid infiltration
Marianna Fontana • 14 Sep 2022
Imaging modalities to diagnose and monitor AL & ATTR amyloidosis
2:14
Imaging modalities to diagnose and monitor AL & ATTR amyloidosis
Marianna Fontana • 14 Sep 2022

Related Videos

How may the timing of TP53 mutation acquisition impact outcomes in patients with MPNs?
2:21
How may the timing of TP53 mutation acquisition impact outcomes in patients with MPNs?
Akriti Jain • 27 May 2026
Tagraxofusp, hyper-CVAD, and venetoclax for patients with BPDCN: Phase II study results
1:40
Tagraxofusp, hyper-CVAD, and venetoclax for patients with BPDCN: Phase II study results
Naveen Pemmaraju • 30 May 2026
How the FDA approval of pivekimab sunirine may shape the field of BPDCN & advice for clinicians
2:20
How the FDA approval of pivekimab sunirine may shape the field of BPDCN & advice for clinicians
Naveen Pemmaraju • 29 May 2026
The importance of alloSCT in improving outcomes for patients with BPDCN
1:40
The importance of alloSCT in improving outcomes for patients with BPDCN
Naveen Pemmaraju • 29 May 2026
The content of VJHemOnc is intended for healthcare professionals